MedMax: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MedMax
Largest movements
- Cash -€8,166
down €8,166 (-78.5%), from €10,402 to €2,236
mainly Net result for the year (-€7,507) and Receivables within one year (-€1,077)
- Receivables within one year +€1,077
up €1,077 (+24.7%), from €4,368 to €5,445
of which Trade receivables: +€1,210
- Tangible fixed assets -€399
down €399 (-41.5%), from €961 to €562
- Deferred charges and accrued income +€190
new in 2025: €190
- Profit (loss) carried forward -€7,507
new in 2025: -€7,507
- Other debts +€158
new in 2025: €158
- Gross operating margin -€11,261
down €11,261, from €4,484 to -€6,777
- Taxes -€874
down €874 (-100%), from €874 to €0
- Other operating charges -€289
down €289 (-51.3%), from €564 to €274
- Depreciation +€163
up €163 (+69.0%), from €236 to €399
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €15,731 | €8,434 | -€7,298 | -46.4% |
| Fixed assets | 21/28 | €961 | €562 | -€399 | -41.5% |
| Tangible fixed assets | 22/27 | €961 | €562 | -€399 | -41.5% |
| Furniture and vehicles | 24 | €961 | €562 | -€399 | -41.5% |
| Current assets | 29/58 | €14,770 | €7,871 | -€6,899 | -46.7% |
| Amounts receivable within one year | 40/41 | €4,368 | €5,445 | +€1,077 | +24.7% |
| Trade receivables | 40 | €4,235 | €5,445 | +€1,210 | +28.6% |
| Other amounts receivable | 41 | €133 | €0 | -€133 | -100% |
| Cash at bank and in hand | 54/58 | €10,402 | €2,236 | -€8,166 | -78.5% |
| Deferred charges and accrued income | 490/1 | - | €190 | +€190 | |
| Total equity and liabilities | 10/49 | €15,731 | €8,434 | -€7,298 | -46.4% |
| Equity | 10/15 | €12,807 | €5,300 | -€7,507 | -58.6% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Reserves | 13 | €2,807 | €2,807 | = | 0.0% |
| Distributable reserves | 133 | €2,807 | €2,807 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | -€7,507 | -€7,507 | |
| Amounts payable | 17/49 | €2,925 | €3,134 | +€209 | +7.2% |
| Amounts payable within one year | 42/48 | €2,925 | €3,134 | +€209 | +7.2% |
| Financial debts | 43 | - | €18 | +€18 | |
| Credit institutions | 430/8 | - | €18 | +€18 | |
| Trade debts | 44 | €178 | €183 | +€5 | +3.1% |
| Suppliers | 440/4 | €178 | €183 | +€5 | +3.1% |
| Taxes, remuneration and social security | 45 | €2,747 | €2,775 | +€28 | +1.0% |
| Taxes | 450/3 | €2,747 | €2,775 | +€28 | +1.0% |
| Other amounts payable | 47/48 | - | €158 | +€158 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €236 | €399 | +€163 | +69.0% |
| Other operating charges | 640/8 | €564 | €274 | -€289 | -51.3% |
| Gross operating margin | 9900 | €4,484 | -€6,777 | -€11,261 | |
| Operating profit (loss) | 9901 | €3,684 | -€7,451 | -€11,135 | |
| Financial charges | 65/66B | €3 | €56 | +€53 | +1,596% |
| Recurring financial charges | 65 | €3 | €56 | +€53 | +1,596% |
| Profit (loss) for the period before taxes | 9903 | €3,681 | -€7,507 | -€11,188 | |
| Income taxes | 67/77 | €874 | €0 | -€874 | -100% |
| Profit (loss) for the period | 9904 | €2,807 | -€7,507 | -€10,314 | |
| Profit (loss) for the period to be appropriated | 9905 | €2,807 | -€7,507 | -€10,314 |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.